CFAP263
gene geneOn this page
Also known as HSPC065DKFZp434N1418
Summary
CFAP263 (cilia and flagella associated protein 263, HGNC:25002) is a protein-coding gene on chromosome 16q21, encoding Cilia- and flagella-associated protein 263 (Q9H0I3). Component of centriolar satellites contributing to primary cilium formation.
Involved in cilium assembly. Located in centriolar satellite and ciliary basal body. Part of protein-containing complex.
Source: NCBI Gene 29070 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 129 total
- MANE Select transcript:
NM_014157
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25002 |
| Approved symbol | CFAP263 |
| Name | cilia and flagella associated protein 263 |
| Location | 16q21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HSPC065, DKFZp434N1418 |
| Ensembl gene | ENSG00000103021 |
| Ensembl biotype | protein_coding |
| OMIM | 616070 |
| Entrez | 29070 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 5 protein_coding, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000219299, ENST00000443128, ENST00000561517, ENST00000566498, ENST00000569374, ENST00000877446, ENST00000954260
RefSeq mRNA: 2 — MANE Select: NM_014157
NM_001142302, NM_014157
CCDS: CCDS10795, CCDS45497
Canonical transcript exons
ENST00000219299 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000686675 | 58253998 | 58254159 |
| ENSE00000853017 | 58249936 | 58250115 |
| ENSE00000921089 | 58278482 | 58278637 |
| ENSE00001047062 | 58267479 | 58267586 |
| ENSE00001860360 | 58279691 | 58283836 |
| ENSE00003565088 | 58262385 | 58262540 |
| ENSE00003575648 | 58258368 | 58258523 |
| ENSE00003591159 | 58259854 | 58259934 |
| ENSE00003675995 | 58252727 | 58252853 |
Expression profiles
Bgee: expression breadth ubiquitous, 229 present calls, max score 99.31.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.4349 / max 315.7795, expressed in 1472 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 154438 | 6.3513 | 1469 |
| 154439 | 0.0509 | 19 |
| 154441 | 0.0327 | 12 |
Top tissues by expression
251 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bronchial epithelial cell | CL:0002328 | 99.31 | gold quality |
| bronchus | UBERON:0002185 | 98.97 | gold quality |
| oviduct epithelium | UBERON:0004804 | 96.94 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 95.21 | gold quality |
| right uterine tube | UBERON:0001302 | 91.13 | gold quality |
| endothelial cell | CL:0000115 | 89.87 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 89.82 | gold quality |
| trachea | UBERON:0003126 | 89.51 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 89.17 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 88.09 | gold quality |
| caput epididymis | UBERON:0004358 | 86.94 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 86.30 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 86.06 | gold quality |
| fallopian tube | UBERON:0003889 | 85.39 | gold quality |
| medial globus pallidus | UBERON:0002477 | 84.00 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 83.08 | gold quality |
| primary visual cortex | UBERON:0002436 | 82.88 | gold quality |
| left testis | UBERON:0004533 | 82.70 | gold quality |
| right testis | UBERON:0004534 | 82.31 | gold quality |
| testis | UBERON:0000473 | 82.17 | gold quality |
| occipital lobe | UBERON:0002021 | 81.82 | gold quality |
| tibia | UBERON:0000979 | 81.71 | gold quality |
| globus pallidus | UBERON:0001875 | 81.67 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 81.44 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 81.38 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 81.37 | gold quality |
| postcentral gyrus | UBERON:0002581 | 80.92 | gold quality |
| entorhinal cortex | UBERON:0002728 | 80.80 | gold quality |
| parietal lobe | UBERON:0001872 | 80.64 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 79.77 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-114 | yes | 11.04 |
| E-ANND-3 | yes | 8.42 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
106 targeting CFAP263, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4692 | 100.00 | 67.32 | 2066 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-4514 | 99.99 | 67.10 | 1870 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-32-5P | 99.98 | 75.21 | 1964 |
| HSA-MIR-92A-3P | 99.98 | 75.21 | 1960 |
| HSA-MIR-92B-3P | 99.98 | 75.25 | 1955 |
| HSA-MIR-25-3P | 99.98 | 74.60 | 1817 |
| HSA-MIR-363-3P | 99.98 | 74.72 | 1821 |
| HSA-MIR-367-3P | 99.98 | 74.83 | 1819 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-4645-5P | 99.98 | 65.81 | 1284 |
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-767-5P | 99.95 | 70.85 | 993 |
| HSA-MIR-5010-5P | 99.94 | 64.11 | 705 |
| HSA-MIR-4525 | 99.94 | 64.38 | 675 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-6753-3P | 99.93 | 66.57 | 637 |
| HSA-MIR-7107-3P | 99.93 | 66.73 | 627 |
Literature-anchored findings (GeneRIF, showing 1)
- CCDC113 promotes colorectal cancer tumorigenesis and metastasis via TGF-beta signaling pathway. (PMID:39261464)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | cfap263 | ENSDARG00000006981 |
| mus_musculus | Ccdc113 | ENSMUSG00000036598 |
| rattus_norvegicus | Ccdc113 | ENSRNOG00000051510 |
Protein
Protein identifiers
Cilia- and flagella-associated protein 263 — Q9H0I3 (reviewed: Q9H0I3)
All UniProt accessions (3): Q9H0I3, H3BMZ8, H3BQS9
UniProt curated annotations — full annotation on UniProt →
Function. Component of centriolar satellites contributing to primary cilium formation. In complex with CFAP263, acts as a regulator of ciliary beating that connects radial spoke 3 (RS3) to the inner dynein arm (IDA) and the nexin-dynein regulatory complex (N-DRC). The complex is positioned parallel to N-DRC and forms a connection between the arch at the base of RS3, the IDA tail and N-DRC.
Subunit / interactions. Forms a complex with CFAP184; the interaction is required for functional activity in cilia. Interacts with HAP1 and PCM1.
Subcellular location. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome. Centriolar satellite. Cell projection. Cilium.
Similarity. Belongs to the CFAP263 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9H0I3-1 | 1 | yes |
| Q9H0I3-2 | 2 |
RefSeq proteins (2): NP_001135774, NP_054876* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR025254 | CCDC113/CCDC96_CC | Domain |
| IPR051885 | CC_CF | Family |
Pfam: PF13870
UniProt features (7 total): coiled-coil region 2, sequence variant 2, chain 1, splice variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 8J07 | ELECTRON MICROSCOPY | 4.1 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H0I3-F1 | 83.57 | 0.54 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 59 (showing top):
GOCC_MICROTUBULE_ORGANIZING_CENTER, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, GOBP_CILIUM_ORGANIZATION, GOCC_CENTROSOME, TCCCCAC_MIR491, GOBP_ORGANELLE_ASSEMBLY, chr16q21, GOBP_CELL_PROJECTION_ORGANIZATION, GOCC_CYTOPLASMIC_REGION, GOCC_CILIUM, GOCC_CILIARY_BASAL_BODY, GOCC_CENTRIOLAR_SATELLITE, ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP, DODD_NASOPHARYNGEAL_CARCINOMA_DN, KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
GO Biological Process (2): cilium assembly (GO:0060271), cell projection organization (GO:0030030)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (8): axoneme (GO:0005930), protein-containing complex (GO:0032991), centriolar satellite (GO:0034451), ciliary basal body (GO:0036064), cytoplasm (GO:0005737), cytoskeleton (GO:0005856), cilium (GO:0005929), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| axoneme assembly | 1 |
| intraciliary transport involved in cilium assembly | 1 |
| cilium organization | 1 |
| protein localization to cilium | 1 |
| organelle assembly | 1 |
| trans-Golgi to periciliary membrane compartment transport | 1 |
| plasma membrane bounded cell projection assembly | 1 |
| ciliary transition zone assembly | 1 |
| cellular component organization | 1 |
| binding | 1 |
| cytoskeleton | 1 |
| microtubule | 1 |
| ciliary plasm | 1 |
| cellular_component | 1 |
| centrosome | 1 |
| microtubule organizing center | 1 |
| cilium | 1 |
| intracellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
Protein interactions and networks
STRING
704 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CFAP263 | DRC7 | Q8IY82 | 644 |
| CFAP263 | DRC12 | Q494R4 | 626 |
| CFAP263 | LRRC23 | Q53EV4 | 607 |
| CFAP263 | SPMIP4 | Q8N865 | 570 |
| CFAP263 | CCDC146 | Q8IYE0 | 544 |
| CFAP263 | CCDC125 | Q86Z20 | 540 |
| CFAP263 | SPAG17 | Q6Q759 | 535 |
| CFAP263 | LYPD2 | Q6UXB3 | 531 |
| CFAP263 | CFAP96 | A7E2U8 | 527 |
| CFAP263 | CCDC81 | Q6ZN84 | 513 |
| CFAP263 | CFAP184 | Q2M329 | 504 |
| CFAP263 | CFAP70 | Q5T0N1 | 494 |
| CFAP263 | LRRIQ1 | Q96JM4 | 491 |
| CFAP263 | CCDC92 | Q53HC0 | 488 |
| CFAP263 | LZTFL1 | Q9NQ48 | 488 |
IntAct
19 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HSF2BP | CFAP263 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LTBR | ZNF724 | psi-mi:“MI:0914”(association) | 0.530 |
| AIFM1 | SEC16A | psi-mi:“MI:2364”(proximity) | 0.420 |
| CFAP263 | H2BC21 | psi-mi:“MI:0915”(physical association) | 0.400 |
| CFAP263 | H1-0 | psi-mi:“MI:0915”(physical association) | 0.400 |
| CFAP263 | PPFIA3 | psi-mi:“MI:0915”(physical association) | 0.400 |
| SMYD1 | CFAP263 | psi-mi:“MI:0915”(physical association) | 0.370 |
| LMTK2 | HAL | psi-mi:“MI:0914”(association) | 0.350 |
| CFAP184 | TARS3 | psi-mi:“MI:0914”(association) | 0.350 |
| CFAP263 | SPTBN2 | psi-mi:“MI:0914”(association) | 0.350 |
| CANX | NACA | psi-mi:“MI:2364”(proximity) | 0.270 |
| CFAP263 | HSF2BP | psi-mi:“MI:0915”(physical association) | 0.000 |
| CFAP263 | GIT1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CFAP263 | HAP1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CFAP263 | IMMT | psi-mi:“MI:0915”(physical association) | 0.000 |
| CFAP263 | PFN2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (24): CCDC113 (Affinity Capture-MS), CCDC113 (Affinity Capture-MS), CCDC113 (Proximity Label-MS), CCDC113 (Proximity Label-MS), GIT1 (Two-hybrid), HAP1 (Two-hybrid), IMMT (Two-hybrid), PFN2 (Two-hybrid), HSF2BP (Two-hybrid), CCDC113 (Proximity Label-MS), CCDC113 (Proximity Label-MS), CCDC113 (Proximity Label-MS), CCDC113 (Affinity Capture-RNA), CCDC113 (Affinity Capture-MS), PPFIA3 (Affinity Capture-MS)
ESM2 similar proteins: A0JMY4, A2AJB1, A3KQH2, A7RNG8, B1H228, E9Q9F7, F1N2N9, F1RKB1, M1V4Y8, Q0VFX2, Q16VW9, Q17QH9, Q28G12, Q2TA00, Q2TAA8, Q3KPZ2, Q3SZX9, Q3T0L1, Q3USS3, Q3UX62, Q3UZ57, Q4R6I5, Q4R8Y5, Q4V7B0, Q502W7, Q5T1B0, Q5T5S1, Q5XIR6, Q5XIR8, Q66H60, Q68CZ6, Q6DCY9, Q6DHI2, Q6PA15, Q8BSN3, Q8C5T8, Q8CDN8, Q8CDV6, Q8IWF9, Q8NA47
Diamond homologs: I7M6D6, Q2M329, Q3SZX9, Q8C5T8, Q95LS7, Q9CR92, Q9H0I3, Q5XJN6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
129 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 97 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1418 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:58250111:CTCAG:C | donor_loss | 1.0000 |
| 16:58250112:TCAG:T | donor_loss | 1.0000 |
| 16:58250113:CAG:C | donor_loss | 1.0000 |
| 16:58250114:AG:A | donor_loss | 1.0000 |
| 16:58250115:GGTAC:G | donor_loss | 1.0000 |
| 16:58250117:T:A | donor_loss | 1.0000 |
| 16:58252725:A:AG | acceptor_gain | 1.0000 |
| 16:58252726:G:GG | acceptor_gain | 1.0000 |
| 16:58252726:GCT:G | acceptor_gain | 1.0000 |
| 16:58252726:GCTAT:G | acceptor_gain | 1.0000 |
| 16:58252849:CACAG:C | donor_loss | 1.0000 |
| 16:58252850:ACAG:A | donor_loss | 1.0000 |
| 16:58252851:CAGG:C | donor_loss | 1.0000 |
| 16:58252852:AGGTA:A | donor_loss | 1.0000 |
| 16:58252853:GGT:G | donor_loss | 1.0000 |
| 16:58252854:G:GC | donor_loss | 1.0000 |
| 16:58252855:T:A | donor_loss | 1.0000 |
| 16:58253988:T:TA | acceptor_gain | 1.0000 |
| 16:58253989:G:A | acceptor_gain | 1.0000 |
| 16:58258356:T:A | acceptor_gain | 1.0000 |
| 16:58258465:G:GT | donor_gain | 1.0000 |
| 16:58278607:G:GT | donor_gain | 1.0000 |
| 16:58278620:A:T | donor_gain | 1.0000 |
| 16:58278633:CAGAG:C | donor_loss | 1.0000 |
| 16:58278634:AGAGG:A | donor_loss | 1.0000 |
| 16:58278635:GAG:G | donor_gain | 1.0000 |
| 16:58278635:GAGG:G | donor_loss | 1.0000 |
| 16:58278636:AGGTG:A | donor_loss | 1.0000 |
| 16:58278637:GGTGA:G | donor_loss | 1.0000 |
| 16:58278639:T:A | donor_loss | 1.0000 |
AlphaMissense
2493 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:58258368:G:C | A131P | 0.996 |
| 16:58258383:G:C | A136P | 0.996 |
| 16:58278632:G:C | A348P | 0.990 |
| 16:58254133:G:C | A122P | 0.987 |
| 16:58259894:T:C | L196P | 0.986 |
| 16:58262485:T:C | L243P | 0.983 |
| 16:58262494:T:C | L246P | 0.983 |
| 16:58258425:T:C | F150L | 0.978 |
| 16:58258427:T:A | F150L | 0.978 |
| 16:58258427:T:G | F150L | 0.978 |
| 16:58262445:G:C | A230P | 0.977 |
| 16:58262431:T:C | L225S | 0.976 |
| 16:58262527:T:C | L257P | 0.976 |
| 16:58267486:T:C | L264P | 0.976 |
| 16:58258393:G:C | R139P | 0.974 |
| 16:58262420:T:A | D221E | 0.973 |
| 16:58262420:T:G | D221E | 0.973 |
| 16:58278536:T:C | F316L | 0.970 |
| 16:58278538:C:A | F316L | 0.970 |
| 16:58278538:C:G | F316L | 0.970 |
| 16:58254140:G:C | R124P | 0.969 |
| 16:58250091:T:C | L26P | 0.967 |
| 16:58254077:T:C | L103P | 0.967 |
| 16:58254146:T:C | L126P | 0.967 |
| 16:58278564:T:A | V325D | 0.967 |
| 16:58278516:T:C | L309P | 0.966 |
| 16:58262419:A:G | D221G | 0.963 |
| 16:58258426:T:C | F150S | 0.962 |
| 16:58262421:T:C | F222L | 0.962 |
| 16:58262423:T:A | F222L | 0.962 |
dbSNP variants (sampled 300 via entrez): RS1000003641 (16:58280355 G>A), RS1000022059 (16:58196472 A>G), RS1000057731 (16:58229251 A>C), RS1000075756 (16:58280128 G>A,T), RS1000108314 (16:58229570 G>A), RS1000136449 (16:58196667 G>A), RS1000138856 (16:58210706 A>C), RS1000173474 (16:58242066 T>G), RS1000185513 (16:58208072 G>A,T), RS1000243231 (16:58201995 T>A), RS1000283943 (16:58235147 C>G,T), RS1000288465 (16:58207571 C>G,T), RS1000312404 (16:58223717 G>A,T), RS1000354468 (16:58248746 T>G), RS1000402320 (16:58235309 A>C)
Disease associations
OMIM: gene MIM:616070 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004302_22 | Primary biliary cholangitis | 2.000000e-08 |
| GCST005752_147 | Systemic lupus erythematosus | 3.000000e-06 |
| GCST005752_34 | Systemic lupus erythematosus | 1.000000e-07 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
31 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression, increases expression | 4 |
| mercuric bromide | decreases expression, affects cotreatment | 2 |
| Air Pollutants | increases abundance, increases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| Tretinoin | decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| methylmercuric chloride | decreases expression | 1 |
| propionaldehyde | increases expression | 1 |
| trichostatin A | decreases expression, increases expression | 1 |
| 3,4-dichloroaniline | decreases expression | 1 |
| potassium chromate(VI) | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Diuron | decreases expression | 1 |
| Folic Acid | decreases expression | 1 |
| Niclosamide | increases expression | 1 |
| Oxygen | decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Thimerosal | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tunicamycin | increases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Acrylamide | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): primary biliary cholangitis